中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2012年
6期
1089-1091
,共3页
张中林%张吉发%艾勇彪%袁玉蜂%何跃明%刘志苏
張中林%張吉髮%艾勇彪%袁玉蜂%何躍明%劉誌囌
장중림%장길발%애용표%원옥봉%하약명%류지소
血管生成素%原核表达载体
血管生成素%原覈錶達載體
혈관생성소%원핵표체재체
Angiopoietin%Prokaryotic expression vector
目的 构建人血管生成素2( Angiopoietin2)原核表达载体.方法 体外培养人脐静脉内皮细胞(HUVECs),通过逆转录-聚合酶链反应(RT-PCR)扩增获取Angiopoietin2基因片段,然后将其克隆入pET32a质粒载体表达系统,实现Angiopoietin2在大肠杆菌BL21中的稳定表达,并通过凝胶电泳、SDS-PAGE及基因测序等对表达蛋白进行鉴定.结果 从HUVEC中克隆出约1.5kb的Angiopoietin2基因,通过pET32a载体系统实现了Angiopoietin2蛋白的表达,SDS-PAGE、电泳及测序分析证实表达成功,融合蛋白相对分子质量为70×103.结论 应用基因重组技术成功构建了人Angiopoietin2原核表达载体.
目的 構建人血管生成素2( Angiopoietin2)原覈錶達載體.方法 體外培養人臍靜脈內皮細胞(HUVECs),通過逆轉錄-聚閤酶鏈反應(RT-PCR)擴增穫取Angiopoietin2基因片段,然後將其剋隆入pET32a質粒載體錶達繫統,實現Angiopoietin2在大腸桿菌BL21中的穩定錶達,併通過凝膠電泳、SDS-PAGE及基因測序等對錶達蛋白進行鑒定.結果 從HUVEC中剋隆齣約1.5kb的Angiopoietin2基因,通過pET32a載體繫統實現瞭Angiopoietin2蛋白的錶達,SDS-PAGE、電泳及測序分析證實錶達成功,融閤蛋白相對分子質量為70×103.結論 應用基因重組技術成功構建瞭人Angiopoietin2原覈錶達載體.
목적 구건인혈관생성소2( Angiopoietin2)원핵표체재체.방법 체외배양인제정맥내피세포(HUVECs),통과역전록-취합매련반응(RT-PCR)확증획취Angiopoietin2기인편단,연후장기극륭입pET32a질립재체표체계통,실현Angiopoietin2재대장간균BL21중적은정표체,병통과응효전영、SDS-PAGE급기인측서등대표체단백진행감정.결과 종HUVEC중극륭출약1.5kb적Angiopoietin2기인,통과pET32a재체계통실현료Angiopoietin2단백적표체,SDS-PAGE、전영급측서분석증실표체성공,융합단백상대분자질량위70×103.결론 응용기인중조기술성공구건료인Angiopoietin2원핵표체재체.
Objective To construct the human Angiopoietin2 prokaryotic expression vector.Methods Complete Angiopoietin2 gene was cloned by reverse transcription-polymerase chain reaction (RTPCR) fromin vitro cultured human umbilical vein endothelial cells (HUVECs),then the gene was cloned into pET32a plasmid expression system,and ultimately Angiopoietin2 was stablely expressed in E.coli BL21.Angiopoietin2 protein was then purified and identified by condensate gel electrophoresis,SDS-PAGE and gene sequencing.Results The cloned Angiopoietin2 gene fragment from HUVECs was about 1.5 Kb,the Angiopoietin2 protein was expressed by pET32a plasmid expression system,and it was predicated about 70 kDa protein by SDS-PAGE.Conclusion The prokaryotic expression vector of Angiopoietin2 is successfully constructed by recombinant DNA techniques.